News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CSA Medical, Inc. Elects Todd Langevin to Board of Directors


12/14/2010 7:00:49 AM

BALTIMORE, Dec. 13, 2010 /PRNewswire/ -- CSA Medical, Inc. (www.CSAmedical.com) today announced the election of Todd Langevin to its Board of Directors. Langevin offers over 20 years of medical device experience including interventional and implantable therapeutic devices, targeted at hypertension, Parkinson's disease, spasticity and pain management.

"We are very pleased to have Todd join the CSA Medical board. He will be a valuable addition to the company as he has broad background in general management, commercial and market development, and clinical and regulatory management," said Vince Owens, Chairman of the CSA Medical board of directors. "We will benefit greatly from his experience as CSA Medical moves to the next stage of growth by entering new clinical areas for Spray Cryotherapy treatment."

Todd recently served as Senior Vice President of Clinical Operations and Commercial Development for CVRx, Inc. Previously he worked at Medtronic for twenty years, most recently as Vice President and General Manager of Medtronic's Global Movement Disorders business. Langevin also managed Medtronic's European Neuromodulation business and held leadership positions in marketing, ventures management, clinical and regulatory affairs.

"I was struck by the potential of this platform technology after observing cases and speaking with current physician users and their patients," said Langevin. "The Spray Cryotherapy device is curing disease today and improving quality of life for patients. The published data to date is quite compelling. I look forward to helping the company reach more organ systems and disease states which, in turn, will help many more patients."

CSA Medical, Inc develops and manufactures a proprietary therapeutic interventional treatment platform, the CryoSpray Ablation System, that delivers therapeutic doses of a cryogen to flash freeze and destroy diseased tissue inside the body. The Company is first to harness the power of extreme cold (-196 C) liquid nitrogen therapeutic energy delivery inside the body. To learn more, please visit www.CSAmedical.com.

SOURCE CSA Medical, Inc.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES